CELGZ : Summary for Celgene Corporation - Contingen - Yahoo Finance

U.S. Markets closed

Celgene Corporation - Contingen (CELGZ)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.21+0.02 (+1.68%)
At close: 4:00 PM EST
People also watch:
CASMGCVRZCARVCFBKGALTW
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.19
Open1.25
Bid0.00 x
Ask0.00 x
Day's Range1.21 - 1.25
52 Week Range0.92 - 1.61
Volume12,842
Avg. Volume10,126
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire9 months ago

    Celgene Notified of ANDA Filing for ABRAXANE®

    Celgene Corporation today announced it has received a Paragraph IV Notice Letter advising that Actavis LLC submitted an Abbreviated New Drug Application to the U.S.

  • We're sorry this is all we were able to find about this topic.